1Bux J. Nomenclature of granulocyte alloantigens. Transfusion, 1999, 39(6) :662-663.
2Bux J. Human neutrophil alloantigens. Vox Sang, 2008, 94 (4) : 277-285.
3Curtis BR, Cox N J, Sullivan MJ, et al. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 (CTL2) and appears to be encoded by an R > Q154 amino acid substitution. Blood, 2009, DOI 10. 1182/blood-2009-11- 248336.
4Greinaeher A, Wesche J, Hammer E, et al. Characterization of the human neutrophil alloantigen-3a. Nat Med, 2010, 16 (1): 45 -48.
6Bertrand G, Duprat E, Lefranc MP, et al. Characterization of human FCGR3B* 02 (HNA-lb, NA2) cDNAs and IMGT standardized description of FCGR3B alleles. Tissue Antigens, 2004, 64(2) :119-131.
7Blum KS, Tong Y, Siebert R, et al. Evidence for gene recombination in FCGR3 gene variants. Vox Sang, 2009, 97(1) :69-76.
8Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet, 2007, 39 (6) : 721-723.
3Van Leeuwen A, Eernisse JG, Van Rood JJ. A New Leucocyte Group with Two Alleles: Leucocyte Group Five. Vox Sang, 1964,4 (9) :431446.
4Greinacher A, Wesehe J, Hammer E, eta|. Characterization of lhe human neutrophil alloantigen-3a. Nat Med ,2010,16( 1 ) :45-48.
5Curtis BR,. Cox N J, Sullivan M J, et al. The neutrophil alloantigen HNA-3a (5b)is located on choline transporter-like protein 2 and appears to be encoded by an RQI54 amino acid substitution Blood,2010,tl5(10) : 2073-2076.
6Curtis BR, Cox N J, Sullivan MJ, et al. The neutrophil alloantigen HNA-3a (Sb)is located on choline transporter-like protein 2 andappears to be encoded by an R > Q154 amino acid substitution. Blood,2010,115(10) :2073-2076.
7Reil A, Wesche J, Greinacher A, et al. Geno- and phenotyping and immunogenicity of HNA-3. Transfusion ,2011,51 ( 1 ) : 18-24.
8Nielsen KR, Koelbaek MD,Varming K,et al. Frequencies of HNA- 1, HNA-3, HNA-4 ,and HNA-5 in the Danish and Zambian popula- tions determined using a novel TaqMan real time polymerase chain reaction method. Tissue Antigens. ? 2012,80(3 ) :249-53.
